<scp>CEACAM6</scp> promotes cisplatin resistance in lung adenocarcinoma and is regulated by <scp>microRNA</scp>‐146a and <scp>microRNA</scp>‐26a

Abstract

CEACAM6 promotes DDP resistance in LUAD by affecting the epithelial-mesenchymal transition (EMT) phenotype and stemness, which is post-transcriptionally regulated by miR-146a and miR-26a.